Profitability Ratios
| Ratio |
Value |
| GP Margin |
35.9% |
| EBIT Margin |
19.5% |
| EBITDA Margin |
23.5% |
| Operating Margin |
20.1% |
| Pretax Margin |
20.0% |
| Cont. Ops Margin |
16.1% |
| Net Margin |
16.1% |
| Bottom Line Margin |
16.1% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.02 |
| Quick Ratio |
2.34 |
| Solvency Ratio |
0.565 |
| Cash Ratio |
1.21 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
34.00 |
| Forward PEG |
34.00 |
| Price/Book |
6.26 |
| Price/Sales |
6.47 |
| Price/FCF |
42.42 |
| Price/Op Cash Flow |
26.35 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0976 |
| Debt/Equity |
0.1312 |
| Debt/Capital |
0.1160 |
| Long-Term Debt/Capital |
0.0859 |
| Financial Leverage |
1.34 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.66 |
| Operating Cash Flow Ratio |
1.153 |
| Operating Cash Flow/Sales |
24.6% |
| Free Cash Flow/Operating Cash Flow |
62.1% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
25.84 |
| Interest Coverage |
1029.0000 |
| Short-Term Operating Cash Flow Coverage |
33.25 |
| Operating Cash Flow Coverage |
1.81 |
| Capital Expenditure Coverage |
2.64 |
| Dividend + Capital Expenditure Coverage |
2.17 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
12.3962% |
| Dividend Yield |
0.3077% |
| Dividend Yield % |
0.3077% |
| Dividend Per Share |
0.8465 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
42.51 |
| EPS |
6.828 |
| Debt/Share |
5.7718 |
| Cash/Share |
10.94 |
| Book Value/Share |
43.93 |
| Tangible BV/Share |
42.30 |
| Equity/Share |
43.93 |
| Operating Cash Flow/Share |
10.440 |
| Capital Expenditure/Share |
3.954 |
| FCF/Share |
6.485 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.802 |
| Earnings Before Tax/EBIT |
0.997 |
| Price/Fair Value |
6.26 |
| Debt/Market Cap |
0.0161 |
| Effective Tax Rate |
19.8% |
| Enterprise Value Multiple |
26.97 |
WST - West Pharmaceutical Services, Inc.